|Event Name||IQPC 2013 Predictive Toxicology
Monday, February 18, 2013
Wednesday, February 20, 2013
|Cost||£499 + VAT - £1499 + VAT
|Description||Implement the latest in-vitro and in-silico models and address the continual challenge of in-vitro to in-vivo extrapolation
The average cost of discovering and developing a drug now costs $900 million. With budget cuts hitting hard in the R&D field, it is imperative to validate the worth of predictive methods internally as they continue to facilitate the reduction in late stage drug attrition.
But the challenges remain: how do we cost-effectively develop and implement these in-vitro methods as accurately and as early in the drug discovery process as possible? How do we demonstrate the validation of these methods?